Peroxisome proliferator-activated receptors in cutaneous biology (Q28202926)

British Journal of Dermatology

Europe PubMed Central

title

Peroxisome proliferator-activated receptors in cutaneous biology (English)

0 references

author name string

S Kuenzli

series ordinal

1

0 references

J-H Saurat

series ordinal

2

0 references

language of work or name

English

0 references

publication date

August 2003

0 references

published in

0 references

volume

149

0 references

issue

2

0 references

page(s)

229-36

0 references

cites work

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

Critical roles of PPAR beta/delta in keratinocyte response to inflammation

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2133.2003.05532.X

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Orphan nuclear receptors: shifting endocrinology into reverse

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

PPARs: transcriptional effectors of fatty acids and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Regulation of gene expression by dietary fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Activation of PPARdelta alters lipid metabolism in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Role of hormones in pilosebaceous unit development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Treatment of psoriasis. Part 1. Topical therapy and phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X

Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05532.X